CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barr, L. F.
Right arrow Articles by Baylin, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barr, L. F.
Right arrow Articles by Baylin, S. B.

Cell Growth & Differentiation, Vol 8, Issue 4 381-392, Copyright © 1997 by American Association of Cancer Research


ARTICLES

Protein kinase C-beta 2 inhibits cycling and decreases c-myc-induced apoptosis in small cell lung cancer cells

LF Barr, SE Campbell and SB Baylin
Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland 21205, USA.

The overexpression of c-myc frequently accompanies the relapse of small cell lung cancer (SCLC) cells and contributes to the poor prognosis of this tumor. In this study, we confirm that transfected c-myc results in decreased homotypic cell aggregation and increased proliferative capacity of SCLC cells when nutrient conditions are adequate. We also find that c-myc contributes to apoptosis when cells are nutrient depleted, and flow cytometry suggests that this enhanced apoptosis is associated with a failure to halt cell cycling, consistent with the experience in other cell types. We previously found that protein kinase C-beta (PKC-beta) expression in NCI H209 (209) SCLC cells increases markedly with c-myc transfection (L. F. Barr et al., Cancer Res., 51: 5514-5519, 1991), and we hypothesized that PKC-beta may mediate some of the effects of c-myc in these cells. We test this hypothesis by transfection of rat PKC-beta 1 and bovine PKC-beta 2 isoforms into 209 cells before and after transfection with c-myc. PKC-beta 1 transfection has no effect on these cells. However, PKC-beta 2 expression has distinct phenotypic consequences. In the parental cells, PKC-beta 2 expression results in increased homotypic cell aggregation and a prolonged doubling time. Furthermore, PKC-beta 2 expression increases the fraction of these cells in G0-G1. In the cells which express a transfected c-myc gene, PKC-beta 2 expression improves the survival of cells in low serum by decreasing myc-induced apoptosis. This effect was associated with, and may be mediated by, a selection for cells in the G0-G1 fraction. We postulate that transfection of c-myc into SCLC cells may select for those expressing the PKC-beta 2 gene because this signal transduction event protects against myc-induced apoptosis.


This article has been cited by other articles:


Home page
JCOHome page
Y. Oh, R. S. Herbst, H. Burris, A. Cleverly, L. Musib, M. Lahn, and G. Bepler
Enzastaurin, an Oral Serine/Threonine Kinase Inhibitor, As Second- or Third-Line Therapy of Non-Small-Cell Lung Cancer
J. Clin. Oncol., March 1, 2008; 26(7): 1135 - 1141.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. S. Herbst, Y. Oh, A. Wagle, and M. Lahn
Enzastaurin, a Protein Kinase C{beta} Selective Inhibitor, and Its Potential Application as an Anticancer Agent in Lung Cancer
Clin. Cancer Res., August 1, 2007; 13(15): 4641s - 4646s.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
A. Hurbin, J.-L. Coll, L. Dubrez-Daloz, B. Mari, P. Auberger, C. Brambilla, and M.-C. Favrot
Cooperation of Amphiregulin and Insulin-like Growth Factor-1 Inhibits Bax- and Bad-mediated Apoptosis via a Protein Kinase C-dependent Pathway in Non-small Cell Lung Cancer Cells
J. Biol. Chem., May 20, 2005; 280(20): 19757 - 19767.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
T. B. Deb, C. M. Coticchia, and R. B. Dickson
Calmodulin-mediated Activation of Akt Regulates Survival of c-Myc-overexpressing Mouse Mammary Carcinoma Cells
J. Biol. Chem., September 10, 2004; 279(37): 38903 - 38911.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Asghar, T. Hussain, and M. F. Lokhandwala
Overexpression of PKC-{beta}I and -{delta} contributes to higher PKC activity in the proximal tubules of old Fischer 344 rats
Am J Physiol Renal Physiol, November 4, 2003; 285(6): F1100 - F1107.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Moon, Y. Oh, and J. A. Roth
Current Status of Gene Therapy for Lung Cancer and Head and Neck Cancer
Clin. Cancer Res., November 1, 2003; 9(14): 5055 - 5067.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
L. Ding, H. Wang, W. Lang, and L. Xiao
Protein Kinase C-{varepsilon} Promotes Survival of Lung Cancer Cells by Suppressing Apoptosis through Dysregulation of the Mitochondrial Caspase Pathway
J. Biol. Chem., September 20, 2002; 277(38): 35305 - 35313.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. C. Dempsey, A. C. Newton, D. Mochly-Rosen, A. P. Fields, M. E. Reyland, P. A. Insel, and R. O. Messing
Protein kinase C isozymes and the regulation of diverse cell responses
Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L429 - L438.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. F. Barr, S. E. Campbell, G. B. Diette, E. W. Gabrielson, S. Kim, H. Shim, and C. V. Dang
c-Myc Suppresses the Tumorigenicity of Lung Cancer Cells and Down-Regulates Vascular Endothelial Growth Factor Expression
Cancer Res., January 1, 2000; 60(1): 143 - 149.
[Abstract] [Full Text]


Home page
J Biol ChemHome page
Y. Tan, H. Ruan, M. R. Demeter, and M. J. Comb
p90RSK Blocks Bad-mediated Cell Death via a Protein Kinase C-dependent Pathway
J. Biol. Chem., December 3, 1999; 274(49): 34859 - 34867.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Ruiz-Ruiz, G. Robledo, J. Font, M. Izquierdo, and A. Lopez-Rivas
Protein Kinase C Inhibits CD95 (Fas/APO-1)-Mediated Apoptosis by at Least Two Different Mechanisms in Jurkat T Cells
J. Immunol., November 1, 1999; 163(9): 4737 - 4746.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Paolucci and E. Rozengurt
Protein Kinase D in Small Cell Lung Cancer Cells: Rapid Activation through Protein Kinase C
Cancer Res., February 1, 1999; 59(3): 572 - 577.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1997 by the American Association of Cancer Research.